Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “COMMISSION”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,801 records · Page 100

Development and characterization of a three-dimensional radiochromic film stack dosimeter for megavoltage photon beam dosimetry

Purpose: Three-dimensional (3D) dosimeters are particularly useful for verifying the commissioning of treatment planning and delivery systems, especially with the ever-increasing implementation of complex and conformal radiotherapy techniques such as volumetric modulated arc therapy. However, currently available 3D dosimeters require extensive experience to prepare and analyze, and are subject to large measurement uncertainties. This work aims to provide a more readily implementable 3D dosimeter with the development and characterization of a radiochromic film stack dosimeter for megavoltage photon beam dosimetry. Methods: A film stack dosimeter was developed using Gafchromic{sup ®} EBT2 films. The dosimeter consists of 22 films separated by 1 mm-thick spacers. A Virtual Water™ phantom was created that maintains the radial film alignment within a maximum uncertainty of 0.3 mm. The film stack dosimeter was characterized using simulations and measurements of 6 MV fields. The absorbed-dose energy dependence and orientation dependence of the film stack dosimeter were investigated using Monte Carlo simulations. The water equivalence of the dosimeter was determined by comparing percentage-depth-dose (PDD) profiles measured with the film stack dosimeter and simulated using Monte Carlo methods. Film stack dosimeter measurements were verified with thermoluminescent dosimeter (TLD) microcube measurements. The film stack dosimeter was also used to verify the delivery of an intensity-modulated radiation therapy (IMRT) procedure. Results: The absorbed-dose energy response of EBT2 film differs less than 1.5% between the calibration and film stack dosimeter geometries for a 6 MV spectrum. Over a series of beam angles ranging from normal incidence to parallel incidence, the overall variation in the response of the film stack dosimeter is within a range of 2.5%. Relative to the response to a normally incident beam, the film stack dosimeter exhibits a 1% under-response when the beam axis is parallel to the film planes. Measured and simulated PDD profiles agree within a root-mean-square difference of 1.3%. In-field film stack dosimeter and TLD measurements agree within 5%, and measurements in the field penumbra agree within 0.5 mm. Film stack dosimeter and TLD measurements have expanded (k = 2) overall measurement uncertainties of 6.2% and 5.8%, respectively. Film stack dosimeter measurements of an IMRT dose distribution have 98% agreement with the treatment planning system dose calculation, using gamma criteria of 3% and 2 mm. Conclusions: The film stack dosimeter is capable of high-resolution, low-uncertainty 3D dose measurements, and can be readily incorporated into an existing film dosimetry program.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

Detector to detector corrections: A comprehensive experimental study of detector specific correction factors for beam output measurements for small radiotherapy beams

Purpose: The aim of the present study is to provide a comprehensive set of detector specific correction factors for beam output measurements for small beams, for a wide range of real time and passive detectors. The detector specific correction factors determined in this study may be potentially useful as a reference data set for small beam dosimetry measurements. Methods: Dose response of passive and real time detectors was investigated for small field sizes shaped with a micromultileaf collimator ranging from 0.6 × 0.6 cm{sup 2} to 4.2 × 4.2 cm{sup 2} and the measurements were extended to larger fields of up to 10 × 10 cm{sup 2}. Measurements were performed at 5 cm depth, in a 6 MV photon beam. Detectors used included alanine, thermoluminescent dosimeters (TLDs), stereotactic diode, electron diode, photon diode, radiophotoluminescent dosimeters (RPLDs), radioluminescence detector based on carbon-doped aluminium oxide (Al{sub 2}O{sub 3}:C), organic plastic scintillators, diamond detectors, liquid filled ion chamber, and a range of small volume air filled ionization chambers (volumes ranging from 0.002 cm{sup 3} to 0.3 cm{sup 3}). All detector measurements were corrected for volume averaging effect and compared with dose ratios determined from alanine to derive a detector correction factors that account for beam perturbation related to nonwater equivalence of the detector materials. Results: For the detectors used in this study, volume averaging corrections ranged from unity for the smallest detectors such as the diodes, 1.148 for the 0.14 cm{sup 3} air filled ionization chamber and were as high as 1.924 for the 0.3 cm{sup 3} ionization chamber. After applying volume averaging corrections, the detector readings were consistent among themselves and with alanine measurements for several small detectors but they differed for larger detectors, in particular for some small ionization chambers with volumes larger than 0.1 cm{sup 3}. Conclusions: The results demonstrate how important it is for the appropriate corrections to be applied to give consistent and accurate measurements for a range of detectors in small beam geometry. The results further demonstrate that depending on the choice of detectors, there is a potential for large errors when effects such as volume averaging, perturbation and differences in material properties of detectors are not taken into account. As the commissioning of small fields for clinical treatment has to rely on accurate dose measurements, the authors recommend the use of detectors that require relatively little correction, such as unshielded diodes, diamond detectors or microchambers, and solid state detectors such as alanine, TLD, Al{sub 2}O{sub 3}:C, or scintillators.

07 ISOTOPE AND RADIATION SOURCES↗

SU-E-I-39: Molecular Image Guided Cancer Stem Cells Therapy

Purpose: Cancer stem cells resistance to radiation is a problematic issue that has caused a big fail in cancer treatment. Methods: As a primary work, molecular imaging can indicate the main mechanisms of radiation resistance of cancer stem cells. By developing and commissioning new probes and nanomolecules and biomarkers, radiation scientist will able to identify the essential pathways of radiation resistance of cancer stem cells. As the second solution, molecular imaging is a best way to find biological target volume and delineate cancer stem cell tissues. In the other hand, by molecular imaging techniques one can image the treatment response in tumor and also in normal tissue. In this issue, the response of cancer stem cells to radiation during therapy course can be imaged, also the main mechanisms of radiation resistance and finding the best radiation modifiers (sensitizers) can be achieved by molecular imaging modalities. In adaptive radiotherapy the molecular imaging plays a vital role to have higher tumor control probability by delivering high radiation doses to cancer stem cells in any time of treatment. The outcome of a feasible treatment is dependent to high cancer stem cells response to radiation and removing all of which, so a good imaging modality can show this issue and preventing of tumor recurrence and metastasis. Results: Our results are dependent to use of molecular imaging as a new modality in the clinic. We propose molecular imaging as a new radiobiological technique to solve radiation therapy problems due to cancer stem cells. Conclusion: Molecular imaging guided cancer stem cell diagnosis and therapy is a new approach in the field of cancer treatment. This new radiobiological imaging technique should be developed in all clinics as a feasible tool that is more biological than physical imaging.

60 APPLIED LIFE SCIENCES↗

SU-E-J-45: Design and Study of An In-House Respiratory Gating Phantom Platform for Gated Radiotherapy

Purpose: The main purpose of this work was to develop an in-house low cost respiratory motion phantom platform for testing the accuracy of the gated radiotherapy system and analyze the dosimetric difference during gated radiotherapy. Methods: An in-house respiratory motion platform(RMP) was designed and constructed for testing the targeting accuracy of respiratory tracking system. The RMP consist of acrylic Chest Wall Platform, 2 DC motors, 4 IR sensors, speed controller circuit, 2 LED and 2 moving rods inside the RMP. The velocity of the movement can be varied from 0 to 30 cycles per minute. The platform mounted to a base using precision linear bearings. The base and platform are made of clear, 15mm thick polycarbonate plastic and the linear ball bearings are oriented to restrict the platform to a movement of approximately 50mm up and down with very little friction. Results: The targeting accuracy of the respiratory tracking system was evaluated using phantom with and without respiratory movement with varied amplitude. We have found the 5% dose difference to the PTV during the movement in comparison with stable PTV. The RMP can perform sinusoidal motion in 1D with fixed peak to peak motion of 5 to 50mm and cycle interval from 2 to 6 seconds. The RMP was designed to be able to simulate the gross anatomical anterior posterior motion attributable to respiration-induced motion of the thoracic region. Conclusion: The unique RMP simulates breathing providing the means to create a comprehensive program for commissioning, training, quality assurance and dose verification of gated radiotherapy treatments. Create the anterior/posterior movement of a target over a 5 to 50 mm distance to replicate tumor movement. The targeting error of the respiratory tracking system is less than 1.0 mm which shows suitable for clinical treatment with highly performance.

60 APPLIED LIFE SCIENCES↗

SU-E-T-50: Automatic Validation of Megavoltage Beams Modeled for Clinical Use in Radiation Therapy

Purpose: To automatically validate megavoltage beams modeled in XiO™ 4.50 (Elekta, Stockholm, Sweden) and Varian Eclipse™ Treatment Planning Systems (TPS) (Varian Associates, Palo Alto, CA, USA), reducing validation time before beam-on for clinical use. Methods: A software application that can automatically read and analyze DICOM RT Dose and W2CAD files was developed using MatLab integrated development environment.TPS calculated dose distributions, in DICOM RT Dose format, and dose values measured in different Varian Clinac beams, in W2CAD format, were compared. Experimental beam data used were those acquired for beam commissioning, collected on a water phantom with a 2D automatic beam scanning system.Two methods were chosen to evaluate dose distributions fitting: gamma analysis and point tests described in Appendix E of IAEA TECDOC-1583. Depth dose curves and beam profiles were evaluated for both open and wedged beams. Tolerance parameters chosen for gamma analysis are 3% and 3 mm dose and distance, respectively.Absolute dose was measured independently at points proposed in Appendix E of TECDOC-1583 to validate software results. Results: TPS calculated depth dose distributions agree with measured beam data under fixed precision values at all depths analyzed. Measured beam dose profiles match TPS calculated doses with high accuracy in both open and wedged beams. Depth and profile dose distributions fitting analysis show gamma values < 1. Relative errors at points proposed in Appendix E of TECDOC-1583 meet therein recommended tolerances.Independent absolute dose measurements at points proposed in Appendix E of TECDOC-1583 confirm software results. Conclusion: Automatic validation of megavoltage beams modeled for their use in the clinic was accomplished. The software tool developed proved efficient, giving users a convenient and reliable environment to decide whether to accept or not a beam model for clinical use. Validation time before beam-on for clinical use was reduced to a few hours.

60 APPLIED LIFE SCIENCES↗

SU-E-T-52: Beam Data Comparison for 20 Linear Accelerators in One Network

Purpose: To compare photon beam data for the 20 Varian linear accelerators (TrueBeam, iX, and EX models) in use at five centers in the same network with the intent to model with one set of beam data in Eclipsec. Methods: Varian linear accelerators, TrueBeam (3), 21 EX, iX, and Trilogy (14), and 6 EX (3), installed between 1999 and 2014 have their 6 MV and 15 MV x-ray beams reevaluated. Full commissioning, including output factors (St), percent depth doses (PDD), and off-axis profiles, was recently performed for a TrueBeam with a cc04 ion chamber in an IBA Blue phantom. Similarly, a subset of beam data for each of the other accelerators was measured recently as follows: for 3×3, 10×10, and 30×30 cm{sup 2} field sizes, flatness and penumbra (80–20%) were measured at dmax and 10 cm depths, PDD were measured at 10 and 20 cm depths, and St were measured at 5 cm depth. Measurement results for all machines were compared. Results: For 15 high-energy (6 and 15 MV) and 3 low-energy machines (6MV only): 1) PDD agreed within 1.4% at 10 and 20 cm depths; 2) penumbra agreed within 1.0 mm at dmax and 10 cm depths; 3) flatness was within 1.3% at dmax and 10 cm depths; and 4) with exception of the three low energy machines, output factors were within 1.1% and 0.5% for 3×3 and 30×30 cm{sup 2}, respectively. Measurement uncertainty, not quantified here, accounts for some of these differences. Conclusion: Measured beam data from 15 high-energy Varian linacs are consistent enough that they can be classified using one beam data set in Eclipse. Two additional high-energy machines are removed from this group until their data are further confirmed. Three low-energy machines will be in a separate class based upon differences in output factors (St)

07 ISOTOPE AND RADIATION SOURCES↗

SU-E-T-136: Dosimetric Robustness of a Magnetic Resonance Imaging Guided Radiation Therapy (MR-IGRT) System

Purpose: To test the radiation delivery robustness of the first MR-IGRT system using a commercial cylindrical diode array detector (ArcCHECK) and an ionization thimble chamber (Exradin A18). Methods: The MR-IGRT system is composed of three evenly spaced Co-60 sources on a rotating gantry located between two magnet halves. The collimator for each source consists of 30 doubly-focused leaf pairs that allow the system to deliver both conformal and intensity modulated (IMRT) treatment plans. The system's delivery robustness was tested over a span of 6 months from September 2013 through February 2014. This was achieved by repeatedly delivering 10 patient plans. These plans consisted of 2 conformal prostates, 2 IMRT prostates, 2 IMRT head and neck, 2 IMRT breast, 1 IMRT pancreas, and 1 IMRT bladder. The plans were generated with the system's treatment planning software. Once the plans were generated, quality assurance plans were created on a digital ArcCHECK dataset. The ArcCHECK used for testing was specially designed to be MR-compatible by moving the power supply outside of the magnetic field. The A18 ionization chamber was placed in a custom plastic plug insert in the center of the ArcCHECK. Gamma analysis was used with the ArcCHECK for relative dose evaluating both 3%/3mm and 2%/2mm. Absolute point dose was compared between ion chamber measurement and treatment plan. Results: The ArcCHECK passing rate remained constant over the 6 month period. The average passing rate for 3%/3mm and 2%/2mm analysis was 98.6% ± 0.7 and 88.8% ± 2.9, respectively. The ion chamber measurements showed little variation with an average percent difference between planned dose verses measured dose of 0.9% ± 0.7. Conclusion: Minimal differences were noted in the delivery of the 10 patient plans. Over a period that included acceptance testing, commissioning, and clinical deliveries, the MR-IGRT system remained consistent in radiation delivery.

60 APPLIED LIFE SCIENCES↗

SU-E-T-173: Evaluation of the MicroSTAR Reader for the OSLD System for Remote Dosimetry Audits at the IROC HQAC

Purpose: Analysis of the performance of the microSTARii reader for optically stimulated luminescence dosimeters (OSLD) used by the IROC Houston Quality Assurance Center (IROC HQAC) for external audits compare to the characteristics of the Microstar reader. Methods: The IROC HQAC uses the Microstar reader for the OSLD program for verification of output of photon, electron and proton beams. The calculation of dose from the OSLD system is based on a group of factors defined at time of the commissioning of a batch of detectors. Factors like system sensitivity (SS), depletion (KD), element correction factor (ECF), linearity (KL), energy correction (KE). The new microSTARii unit presents many hardware and software upgrades that were considered useful for this program. Based on these changes many factors, that were considered reader dependent, were revised in order to analyze the effect of the new reading process. The SS, KD, ECF and KL were evaluated and compared with data defined based on reading done on Microstar reader. Results: The SS is reader specific and specified at 100 cGy dose level. This value is define per reading session and monitored over time. The KD factor was found to be different because of reading procedure are different. The ECF values changed for a group of nano dots compare to values defined based on reading done on the Microstar reader. The KL was defined for the reader. Conclusion: The new microSTARii reader presents new features that improve the efficiency of the OSLD program at the IROC HQAC. New characterization is needed before final implementation is done to match the requirements of the existing OSLD system defined for the Microstar reader. Changes in uncertainty of the results has not been analized.

07 ISOTOPE AND RADIATION SOURCES↗

SU-E-T-213: Initial Experience with VMAT Plan and Delivery Verification Using a DICOM-RT Framework and Linac Delivery Log Files

Purpose: Mobius3D/MobiusFX (M3D/MFX), a commercial DICOM-RT based plan and delivery verification system, was used to compare calculated and delivered volumetric modulated arc therapy (VMAT) dose distributions using TrueBeam delivery log files (TrajectoryLogs). Methods: M3D/MFX utilizes measured linac commissioning data to generate institution specific beam models for evaluating planned and delivered dose distributions. 30 RapidArc prostate plans and 30 head and neck SmartArc plans were used in this study. For every plan, CT images, contoured structure sets, RT-plan, and RT-dose files were exported to M3D, which recalculated the patients’ planning CT dose distributions using a collapsed-cone-convolutionsuperposition algorithm. MFX utilized the acquired TrajectoryLogs to compute patients’ delivered dose distributions based on actual treatment delivery parameters. The agreement between computed and delivered dose distributions was evaluated utilizing a (3%, 3mm) global 3D-gamma analysis and dose-volume histogram changes for targets and organs at risk. Results: Excellent 3D-gamma agreements were observed for all VMAT plans. On average, for computed and delivered RapidArc and SmartArc plans the gamma passing rates were (99.0%±1.4%) and (96.8%±1.8%), respectively. The average difference for primary target prescription dose percent-coverage between calculated and delivered plans was (− 0.09%±2.52%) for RapidArc and (−2.71%±4.62%) for SmartArc cases. Similarly, the planning target mean dose differences were (1.38%±0.96%) for RapidArc and (1.17%±0.72%) for SmartArc plans. For the prostate plans, the calculated and delivered variations of the maximum dose for a 2cc volume for bladder and rectum were (1.32%±1.26%) and (0.65%±1.44%), respectively. The spinal-cord 2cc maximum dose differences of (3.26%±1.68%) were observed for the SmartArc plans. Conclusions: Clinical quality assurance practice based on linac treatment log files for verification of delivered 3D dose distributions in the patients’ geometries represents a paradigm shift from dose measurements in a phantom. This approach captures treatment planning beam modeling differences as well as the linac uncertainties during treatment delivery of the plan.

60 APPLIED LIFE SCIENCES↗

SU-E-T-319: The Effect of Slice Thickness On IMRT Planning

Purpose: The accuracy of volume estimated of a treatment planning system is investigated in this study. In addition, the effect of slice thickness on IMRT planning is also studied. Methods: The accuracy in volume determination was investigated using a water phantom containing various objects with known volumes ranging from 1–100cm{sup 3}. The phantom was scanned with different slice thickness (1–10 mm). The CT data sets were sent to Eclipse TPS for contour delineation and volume calculation. The effect of slice thickness on IMRT planning was studied using a commercial phantom containing four different shaped objects. The phantom was scanned with different slice thickness (1–5 mm). IMRT plans were generated for the different CT datasets to calculate TCP, homogeneity (HI) and conformity indices (CI). Results: The variability of volumes with CT slice thickness was significant especially for small volume structures. The minimum and maximum error in the volume estimation is in the range of −2.3% to 92%. On the other hand, with increasing slice thickness, the PTV mean dose and TCP values decreases. Maximum variation of ∼5% was observed in mean dose and ∼2% in TCP with slice thickness change from 1–5 mm. The relative decrease in target volume receiving 95% of prescribed dose is ∼5% slice thickness change from 1–5 mm. HI increases up to 163% and CI decreases by 4% between 1–5 mm slice thickness change, producing highly inhomogeneous and least conformal plan. Conclusion: Accuracy of volume estimation is dependent on CT slice thickness and the contouring algorithm in a TPS. During TPS commissioning and for all clinical protocols, evaluation of volume should be included to provide the limit of accuracy in DVH calculation. A smaller slice thickness provides superior dosimetry with improved TCP values. Thus, the smallest possible slice thickness should be used for IMRT planning.

07 ISOTOPE AND RADIATION SOURCES↗

SU-E-T-462: Fixed-Jaw Optimization for Critical Structure Sparing in IMRT Treatment Planning: Beam Modeling Cautions for Non-Routine Use

Purpose: Multiple publications exist concerning fixed-jaw utilization to avoid linac carriage shifts and reduce intensity modulated radiotherapy (IMRT) treatment times. The purpose of this work is to demonstrate delivery QA discrepancies and illustrate the need for improved treatment planning system (TPS) commissioning for non-routine use. Methods: A 6cm diameter spherical target was delineated on a virtual phantom containing the Iba Matrixx linear array within the Varian Eclipse TPS. Optimization was performed for target coverage for the following 3 scenarios: a single open, zero degree field where the X and Y jaws completely cover the target; the same field using an asymmetric, fixed-jaw technique where the upper Y jaw does not cover the superior 2cm of the target; and both of the aforementioned directed at the target at 315 and 45 degree gantry angles, respectively. This final orientation was also irradiated on a linac for delivery analysis. A sarcoma patient case was also analyzed where the fixed jaw technique was utilized for kidney sparing. Results: The open beam results were as predicted but the fixed-jaw results demonstrate a pronounced fluence increase along the asymmetric, upper jaw. Analysis of the delivery of the combined beam plan Resultin 83% of pixels evaluated passing gamma criteria of 3%, 3mm DTA. Analysis for the sarcoma patient, in the plane of the shielded kidney, indicated 93% passing although the maximum dose discrepancies in this region were approximately 23%. Conclusion: Optimization within the target is routinely performed using MLC leaf-end characteristics. The fixed-jaw technique forces optimization of target coverage to utilize the penumbra profiles of the associated beamdefining jaw. If the profiles were collected using a common 0.125cc ionization chamber, the resolution may be insufficient resulting in a planvs.-delivery mismatch. It is recommended that high-resolution beam characteristics be considered when non-routine planning methods are utilized.

60 APPLIED LIFE SCIENCES↗

SU-E-T-485: Investigation of a Synthetic Diamond Detector for Tomotherapy Dosimetry

Purpose: Tomotherapy treatments are characterized by rotational deliveries of flattening-filter free fields resulting in high-gradient dose distributions. Small volume, rotationally independent detectors are needed for accurate dosimetry. PTWs microDiamond detector, with its small sensitive volume (0.004mm{sup 3}), could potentially be an ideal detector for Tomotherapy. The microDiamond detector was tested against a small volume Exradin A1SL ion chamber for Tomotherapy open-field and IMRT commissioning measurements. Methods: Custom detector holders were fabricated to allow A1SL and microDiamond measurements in the Tomotherapy Cheese phantom and a square solid water phantom. The microDiamond rotational dependence within the Tomotherapy phantom was tested by incrementally rotating the detector in between static-gantry angle Tomotherapy irradiations. Longitudinal Tomotherapy profiles, for all field sizes, were measured with the microDiamond and A1SL detectors at 1.5cm depth in the square phantom, and compared to film. Detector axes were aligned parallel to table motion. Per TG-119 recommendations, both detectors were calibrated to known doses in phantoms and used to measure high-dose points in TG-119 H and N and Prostate plans. The measurements were compared to the treatment planning system and subsequently compared to published TG-119 confidence limits. Results: The microDiamond angular dependence was less than 0.5%. The average difference between the detectors and film-measured longitudinal profile 80–20% penumbras were 0.03+/-0.04mm and 1.36+/-0.22mm for the microDiamond and A1SL, respectively. The average difference between the detector and filmmeasured field sizes were 0.07+/-0.01mm and 0.09+/-0.02mm for the microDiamond and A1SL, respectively. The measured confidence limits were 0.023 and 0.015 for microDiamond and A1SL, respectively. TG-119 reported a confidence limit of 0.034. Conclusion: The microDiamond measured open-field longitudinal Tomotherapy profiles more closely resembled film measurements, compared with the A1Sl chamber. Furthermore, the microDiamond was shown to have low angular dependence and both detectors were able to accurately measure the highdose points in TG-119 H and N and prostate plans. Our institution has research grants with PTW.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

SU-E-T-555: A Protontherapy Inverse Treatment Planning System Prototype with Linear Energy Transfer (LET) Optimization

Purpose: Develop and benchmark an inverse treatment planning system (TPS) for proton radiotherapy integrating fast analytical dose and LET calculations in patient geometries and a dual objective function with both dose and LET components, enabling us to apply optimization techniques to improve the predicted outcome of treatments based on radiobiological models. Methods: The software package was developed in MATLAB and implements a fluence-dose calculation technique based on a pencil beam model for dose calculations and a 3D LET model based on the extension of the LET in the radial direction as a function of the predicted radiological pathway. Both models were benchmarked against commissioning data from our institution, dose calculations performed with a commercial treatment planning system and Monte Carlo simulations. The optimization is based on the adaptive simulated annealing approach . Results: The dose and LET calculations were tested in a water phantom and several real patient treatments. The pass rate for the gamma index analysis (3%/3mm) test was above 90% for all test cases analyzed, and the calculation time was of the order of seconds. The inverse planning module produced plans with a significantly higher mean LET in the target compared to traditional plans, without any loss of target coverage. The clinical relevance of this improvement is under consideration . Conclusion: The developed treatment planning system is a valuable clinical and research tool that enables us to incorporate LET effects into proton radiotherapy planning in a streamlined fashion.

62 RADIOLOGY AND NUCLEAR MEDICINE↗

SU-F-BRE-09: Linac Isocenter Quality Assurance: A Stereotactic Approach

Purpose: A quantitative method was designed to independently determine the couch/collimator/gantry isocenters, as well as the overall LINAC mechanical isocenter in 3D. Methods: Performed on both a Varian TrueBeam™ STx and Trilogy with the gold standard front pointer positioned at 100 cm SAD, and a Radionics XKnife™ (RX) attached to the couch. At gantry and couch 0°, the RX laser alignment attachment (RXLAA) was centered to the front pointer using the micrometers (0.1-mm precision) on the RX. The 3D coordinates of the micrometers were recorded. The collimator was rotated to 90° and 270°. At each collimator rotation, the RXLAA was re-centered to the front pointer and the micrometer coordinates recorded. At collimator and gantry 0°, the process was repeated for couch angles 0°/90°/270°. Finally, at collimator and couch 0°, the steps were repeated for gantry rotations 0°/90°/180°/270°. The centers/radii of the smallest bounding spheres for the collimator, couch and gantry walkout were calculated (using MatLab™). The smallest bounding sphere containing the collimator, couch and gantry walkout spheres was then calculated. The center of this all-encompassing sphere is the overall mechanical isocenter of the LINAC. This position was dialed in on the RX. LINAC mechanical and radiation isocenter coincidence was determined by performing Winston- Lutz test at four cardinal gantry angles. Results: TrueBeam and Trilogy mechanical isocenters had overall walkout radii of 0.8 mm and 1.5 mm, respectively. For the TrueBeam and Trilogy 6-MV beams, the radii of radiation isocenter were 0.3 mm and 0.4 mm, respectively, with distances between LINAC mechanical and radiation isocenters of 0.5 mm and 0.9 mm, respectively. Conclusion: This efficient and simple method allows for an independent and reliable quantitative assessment of LINAC isocenter in 3D with equipment typically available in a radiation oncology clinic. It can easily be performed for LINAC commissioning and annual QA.

07 ISOTOPE AND RADIATION SOURCES↗

TU-D-BRD-01: Image Guided SBRT II: Challenges ' Pitfalls

Stereotactic body radiation therapy (SBRT) has been effective treatment for the management of various diseases, which often delivers high radiation dose in a single or a few fractions. SBRT therefore demands precise treatment delivery to the tumor while sparing adjacent healthy tissue. Recent developments in image guidance enable target localization with increased accuracy. With such improvements in localization, image-guided SBRT has been widely adopted into clinical practice. In SBRT, high radiation dose is generally delivered with small fields. Therefore, it is crucial to accurately measure dosimetric data for the small fields during commissioning. In addition, image-guided SBRT demands accurate image localization to ensure safety and quality of patient care. Lately, the reports of AAPM TG 142 and TG 104 have been published and added recommendations for imaging devices that are integrated with the linear accelerator for SBRT. Furthermore, various challenges and potential pitfalls lie in the clinical implementation of image-guided SBRT. In this lecture, these challenges and pitfalls of image-guided SBRT will be illustrated and discussed from dosimetric, technical and clinical perspectives.Being a promising technique, image-guided SBRT has shown great potentials, and will lead to more accurate and safer SBRT treatments. Learning Objectives: To understand dosimetric challenges and pitfalls for IGRT application in SBRT. To understand major clinical challenges and pitfalls for IGRT application in SBRT. To understand major technical challenges and pitfalls for IGRT application in SBRT.

60 APPLIED LIFE SCIENCES↗

WE-F-BRD-01: HDR Brachytherapy II: Integrating Imaging with HDR

In recent years, with the advent of high/pulsed dose rate afterloading technology, advanced treatment planning systems, CT/MRI compatible applicators, and advanced imaging platforms, image-guided adaptive brachytherapy treatments (IGABT) have started to play an ever increasing role in modern radiation therapy. The most accurate way to approach IGABT treatment is to provide the infrastructure that combines in a single setting an appropriate imaging device, a treatment planning system, and a treatment unit. The Brachytherapy Suite is not a new concept, yet the modern suites are incorporating state-of-the-art imaging (MRI, CBCT equipped simulators, CT, and /or US) that require correct integration with each other and with the treatment planning and delivery systems. Arguably, an MRI-equipped Brachytherapy Suite is the ideal setup for real-time adaptive brachytherapy treatments. The main impediment to MRI-IGABT adoption is access to MRI scanners. Very few radiation oncology departments currently house MRI scanners, and even fewer in a dedicated Brachytherapy Suite. CBCT equipped simulators are increasingly offered by manufacturers as part of a Brachytherapy Suite installation. If optimized, images acquired can be used for treatment planning, or can be registered with other imaging modalities. This infrastructure is relevant for all forms of brachytherapy, especially those utilizing multi-fractionated courses of treatment such as prostate and cervix. Moreover, for prostate brachytherapy, US imaging systems can be part of the suite to allow for real-time HDR/LDR treatments. Learning Objectives: Understand the adaptive workflow of MR-based IGBT for cervical cancer. Familiarize with commissioning aspects of a CBCT equipped simulator with emphasis on brachytherapy applications Learn about the current status and future developments in US-based prostate brachytherapy.

60 APPLIED LIFE SCIENCES↗

TH-C-19A-08: PDD Discrepancies at Opposite Biases From Very Small Volume Ion Chambers When Using Water Scanners

Purpose: As more so-called micro ion chambers become commercially available, medical physicists may be inclined to use them during the linear accelerator commissioning process, in an attempt to better characterize the beam in steep dose gradient areas. The purpose of this work is to inform the medical physics community of a non-trivial, anomalous behavior observed when very small chambers are used in certain beam scanning configurations. Methods: A total of six ion chambers (0.007cc to 0.6cc) were used to scan PDDs from a 10×10cm2 field at both +300V and −300V biases. PDDs were scanned using three different water tank scanning systems to determine whether different scanners exhibit the same abnormality. Finally, PDDs were sampled using an external electrometer to bypass the internal electrometer of the scanner to determine the potential contributions of the scanner electronics to the abnormality observed. Results: We observed a reproducible, significant difference (over-response with depth) in PDDs acquired when using very small ion chambers with certain bias and watertank combinations, on the order of 3–5% at a depth of 25 cm in water. This difference was not observed when the PDDs were sampled using the ion chambers in conjunction with an external electrometer. This suggests a contribution of interference produced by the controller box and scanning system, which becomes significant for the very small signals collected by very small ion chambers, especially at depth, as the signal level is reduced even further. Conclusion: Based on the results observed here, if currently available very small ion chambers are used with specific bias and scanning water-tank combinations, erroneous PDD data may be collected. If this data is used as input to the Treatment Planning System, systematic errors on the order of 3%–5% may be introduced into the treatment planning process.

07 ISOTOPE AND RADIATION SOURCES↗

Poster — Thur Eve — 56: Design of Quality Assurance Methodology for VMAT system on Agility System equipped with CVDR

The aim of this study was to analyze the feasibility of designing comprehensive QA plans using iComCAT for Elekta machines equipped with Agility multileaf collimator and continuously variable dose rate. Test plans with varying MLC speed, gantry speed, and dose rate were created and delivered in a controlled manner. A strip test was designed with three 1 cm MLC positions and delivered using dynamic, StepNShoot and VMAT techniques. Plans were also designed to test error in MLC position with various gantry speeds and various MLC speeds. The delivery fluence was captured using the electronic portal-imaging device. Gantry speed was found to be within tolerance as per the Canadian standards. MLC positioning errors at higher MLC speed with gravity effects does add more than 2 mm discrepancy. More tests need to be performed to evaluate MLC performance using independent measurement systems. The treatment planning system with end-to-end testing necessary for commissioning was also investigated and found to have >95% passing rates within 3%/3mm gamma criteria. Future studies involve performing off-axis gantry starshot pattern and repeating the tests on three matched Elekta linear accelerators.

07 ISOTOPE AND RADIATION SOURCES↗

Refine your search to explore more results.